Lowell Kabnick, New York, USA, successfully persuaded 84% of delegates to support his argument against the motion “Tumescent anaesthesia is no longer a benefit in superficial vein ablation in the office.” He explained that there was no “level one evidence” for tumescentless procedures at present. His opponent (who received 16% of the vote) was Steve Elias (Englewood, USA).
Also at CX today, Kabnick won 76% of the vote in the debate “Foam sclerotherapy for truncal ablation is underused”. He was again arguing against the motion. He said: “Foam sclerotherapy is overused, it is not as efficacious as ablation, there is concern about stroke, and it is not approved by the FDA.” His opponent was Jonothan Earnshow, Gloucester, UK, who only received 24% of the vote in his bid to support the motion of the debate.